These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

106 related items for PubMed ID: 6340865

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. [Clinical effects of labetalol in 21 patients with phaeochromocytoma (author's transl)].
    Yoshinaga K, Arakawa K, Ikeda M, Ebihara T, Oe N.
    Horumon To Rinsho; 1981 Apr; 29(4):515-22. PubMed ID: 7296922
    [No Abstract] [Full Text] [Related]

  • 3. [Malignant pheochromocytoma: blood pressure controlled by labetalol].
    Sugano O, Hirano J, Hirano K, Kubota Y, Numasawa K, Kawamura S.
    Nihon Hinyokika Gakkai Zasshi; 1984 Mar; 75(3):523-7. PubMed ID: 6471663
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Effect of labetalol on blood pressure and plasma catecholamine concentrations in patients with phaeochromocytoma.
    Reach G, Thibonnier M, Chevillard C, Corvol P, Milliez P.
    Br Med J; 1980 May 31; 280(6227):1300-1. PubMed ID: 7388518
    [No Abstract] [Full Text] [Related]

  • 6. Hypertensive response to labetalol in phaeochromocytoma.
    Briggs RS, Birtwell AJ, Pohl JE.
    Lancet; 1978 May 13; 1(8072):1045-6. PubMed ID: 76965
    [No Abstract] [Full Text] [Related]

  • 7. [Labetalol in the intraoperative control of pheochromocytoma].
    Janjić I, Luetić V.
    Lijec Vjesn; 1983 May 13; 105(7-8):304-6. PubMed ID: 6633151
    [No Abstract] [Full Text] [Related]

  • 8. Falsely high urinary catecholamines induced by labetalol.
    Kobayashi K, Miura Y, Tomioka H, Sakuma H, Adachi M, Abe K, Yoshinaga K.
    Tohoku J Exp Med; 1979 Jan 13; 127(1):63-9. PubMed ID: 760251
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Labetalol in the preoperative management of phaeochromocytoma.
    Russell WJ, Kaines AH, Hooper MJ, Frewin DB.
    Anaesth Intensive Care; 1982 May 13; 10(2):160-3. PubMed ID: 6125109
    [No Abstract] [Full Text] [Related]

  • 14. [Effects of alpha-and beta-adrenoceptor blocking agent (YM-09538) upon the clinical features of a patient with pheochromocytoma].
    Matsuura H, Koyama S, Tsuchioka Y, Yoshida M, Kurogane H.
    Horumon To Rinsho; 1982 Dec 13; 30(12):1439-46. PubMed ID: 6130862
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. [Labetalol: a field study in essential hypertension (author's transl)].
    Greminger P, Minder F, Schärer HU.
    Schweiz Rundsch Med Prax; 1982 Feb 23; 71(8):332-6. PubMed ID: 7041108
    [No Abstract] [Full Text] [Related]

  • 18. Labetalol: the nineteen-eighties.
    Robertson JI.
    Br J Clin Pharmacol; 1982 Jun 23; 13(1 Suppl):137S-141S. PubMed ID: 7093098
    [No Abstract] [Full Text] [Related]

  • 19. [Diazoxide vs. labetalol: a cross-over comparison of acute effects in hypertensive patients (author's transl)].
    Rumboldt Z, Bagatin J, Vidović A.
    Lijec Vjesn; 1980 Nov 23; 102(11):619-23. PubMed ID: 7024692
    [No Abstract] [Full Text] [Related]

  • 20. [Open clinical trial of labetalol in ambulatory patients with arterial hypertension].
    Baratta L, Florio P, Guerrieri P, Lanciotti G, Mastrocola C, Petrosillo N, Scarfò G, Avella A.
    Clin Ter; 1981 Oct 31; 99(2):139-47. PubMed ID: 7032831
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.